Search
A case of hemorrhagic occlusive retinal vasculitis (HORV) following intraocular injections of a compounded triamcinolone, moxifloxacin, and vancomycin formulation
… of patients who have received intraocular injections of vancomycin (anti-infective) formulations toward the end of … (steroid), moxifloxacin (anti-infective), and vancomycin formulation. Adverse Event FDA received an adverse … of a compounded triamcinolone, moxifloxacin, and vancomycin (TMV) formulation in each eye at the conclusion of …
Vancomycin – Injection products
… /drugs/development-resources/vancomycin-injection-products … Recognized Interpretive … pneumoniae … Center for Drug Evaluation and Research … Vancomycin – Injection products … Vancomycin – Injection products …
FDA Rationale for Recognition Decision: Daptomycin
… (STIC) for daptomycin for Enterococcus faecalis (including vancomycin-susceptible and vancomycin-resistant isolates) based on a dosing regimen of 4 … BPs should be revised only for E. faecalis (including vancomycin-susceptible and vancomycin-resistant isolates). …
Drug Trials Snapshots: BAXDELA
… to the standard antibacterial combination therapy of vancomycin and aztreonam in stopping the spread of ABSSSI. … with ABSSSI in Trial 1 and Trial 2 Trial BAXDELA IV Vancomycin+Aztreonam IV Treatment Difference** (2-sided 95% … (78.2%) 266 (80.9%) -2.6 (-8.8, 3.6) BAXDELA IV and oral Vancomycin+Aztreonam IV Treatment Difference** (2-sided 95% …
Daptomycin Injection Products
… mm) Pathogen S I R S I R Enterococcus faecalis (including vancomycin-resistant isolates)* ≤2 4 ≥8 - - - Staphylococcus …
Withdrawn | Infectious Disease Accelerated Approvals
… Synercid (dalfopristin/quinupristin) For the treatment of vancomycin-resistant enterococcus faecium (VREF) 9/21/1999 …
Drug Trials Snapshot: DALVANCE (dalbavancin)
… they were treated with DALVANCE or the comparison drug (Vancomycin/linezolid). Age: The frequency of side … given DALVANCE and 653 others received a combination of Vancomycin and linezolid, which has been the standard therapy … were taking DALVANCE and which patients were taking Vancomycin/linezolid, until after the drug trial was …
July - September 2019 | Potential Signals of Serious Risks/New Safety Information Identified by the FDA Adverse Event Reporting System (FAERS)
… FDA is evaluating the need for regulatory action. Firvanq (vancomycin hydrochloride) Vancocin (vancomycin hydrochloride) Generic products containing vancomycin Serious cutaneous adverse reactions, including …
Oritavancin diphosphate – Injection
… M100 standard is recognized - - - Enterococcus spp. (vancomycin-susceptible isolates only) M100 standard is …
Telavancin – Injection Products
… M100 standard is recognized - - - Enterococcus faecalis (vancomycin‑susceptible isolates only) M100 standard is …
Tigecycline – Injection products
… pneumoniae ≤0.06 a - - ≥19 - - Enterococcus faecalis (vancomycin-susceptible isolates) ≤0.25 a - - ≥19 - - …
Drug Trials Snapshots: ZINPLAVA
… = Standard of Care antibacterial drugs (metronidazole or vancomycin or fidaxomicin) for CDI ‡ Adjusted difference of … stratified by SoC antibacterial drugs (metronidazole vs. vancomycin vs. fidaxomicin) and hospitalization status … = Standard of Care antibacterial drugs (metronidazole or vancomycin or fidaxomicin) for CDI ZINPLAVA Prescribing …
FDA Drug Safety Communication: Serious CNS reactions possible when linezolid (Zyvox) is given to patients taking certain psychiatric medications
… with linezolid such as when: Linezolid is used to treat vancomycin-resistant Enterococcus faecium (VRE) infections. …
Improving Dose Selection In Children through Better Estimates of Renal Function
… three additional drugs—namely, gadoterate, amikacin, and vancomycin—were selected because their elimination ensues …
Antibacterial Susceptibility Test Interpretive Criteria
… Trimethoprim and sulfamethoxazole Oral, Injection Yes Yes Vancomycin Injection Yes Yes Vancomycin* Oral No No *No STIC are recognized by FDA for …
Dalbavancin Injection Products
… M100 standard is recognized - - - Enterococcus spp.(vancomycin-susceptible isolates only) M100 standard is …
Competitive Generic Therapy Approvals
… Inc. Penciclovir Cream, 1% 8/7/2023 Yes No 9/1/2023 223 Vancomycin, NDA 209481 217401 Eugia US LLC Vancomycin Hydrochloride for Injection USP, 1.25 g/vial and … Capsules, 140 mg/125mg/125 mg 7/3/2023 Yes No 7/3/2023 215 Vancomycin Hydrochloride, NDA 209481 217489 Hikma …
Compounding Risk Alerts
… of a compounded triamcinolone, moxifloxacin, and vancomycin formulation (October 3, 2017) FDA investigates …
ANDA (Generic) Drug Approvals in 2016
… transfusions in patients 2 years of age and older 3 091532 Vancomycin Hydrochloride for Injection USP , 100g PBP Samson Medical Technoligies, LLC Vancomycin Hydrochloride for Injection USP , 100g 1/6/2016 …
FYs 2013 - 2017 Regulatory Science Report: Analysis of Generic Drug Utilization and Substitution
… salmon nasal spray, enoxaparin injection, acarbose tablet, vancomycin capsule, and sodium ferric gluconate injection. … initiating brand-name and generic versions of venlafaxine, vancomycin, acarbose, calcitonin salmon, and enoxaparin in …
FDA alerts health care professionals of risks associated with intraocular use of compounded moxifloxacin
… inflammatory responses to moxifloxacin, cefuroxime, and vancomycin on retinal vascular cells. Sci Rep. 9:9745. …
2022 First Generic Drug Approvals
… for use with magnetic resonance imaging 99 214913 Vancomycin Hydrochloride for Oral Solution USP , 25 mg/mL and 50 mg/mL Alkem Laboratories Limited Firvanq Kit (Vancomycin Hydrochloride) for Oral Solution 11/14/2022 …
FDA Drug Safety Communication: Clostridium difficile associated diarrhea can be associated with stomach acid drugs known as proton pump inhibitors (PPIs)
… -associated disease defined by prescription for oral vancomycin therapy. CMAJ . 2006;175(7):745-748. Dial S, …
Comunicado de la FDA sobre la seguridad de los medicamentos: La diarrea asociada con Clostridum difficile puede estar relacionada con los medicamentos contra la acidez estomacal denominados inhibidores de la bomba de protones (PPIs por sus siglas en inglés)
… -associated disease defined by prescription for oral vancomycin therapy. CMAJ . 2006;175(7):745-748. Dial S, …
Accelerated and Restricted Approvals Under Subpart H (drugs) and Subpart E (biologics)
… 5-Sep-97 21-Sep-99 7.8d S Treatment of vancomycin resistant Enterococcus faecium 21029 Temodar …